GSK3B and Alzheimer disease: Many clinically validated targets related to AD were caught, including APP, neuronal acetylcholine receptor subunit α-7 (CHRNA7), acetylcholinesterase (AChE), GSK3β, prostaglandin GH synthase 1, 2 (PTGS1 and PTGS2), and so on.